Find Clinical Trials
Early effect of agomelatine on general interest in outpatients with Major Depressive Disorder. A 12-week, randomized, double-blind, multicentre study with parallel groups: agomelatine (25mg/day given orally with blinded potential adjustment to 50mg/day) versus escitalopram (10mg/day given orally with blinded potential adjustment to 20mg/day).
Servier Protocol Code:
CL3-20098-083
Sponsor:
Institut de Recherches Internationales Servier (I.R.I.S)
EudraCT Number:
2010-023576-10
Find a recruiting site
Name:
Institut de Recherches Internationales Servier, Département des études cliniques
Phone number:
+33 1 55 72 60 00
Results
English (USA)Interventions / Treatments
The treatment(s) given to the participants in the study.
- Major Depressive Disorder
- AGOMELATINE
- S020098
Other study id numbers
Other identification numbers the study may be known by.
- CL3-20098-083